calcium channel blockers

Preferred Label : calcium channel blockers;

MeSH definition : A class of drugs that act by selective inhibition of calcium influx through cellular membranes.;

MeSH synonym : blockers, calcium channel; calcium channel blocking drugs; channel blockers, calcium; Calcium Channel Antagonists; Antagonists, Calcium Channel; Calcium Channel Blocking Drug; Calcium Channel Antagonist; Antagonist, Calcium Channel; Channel Antagonist, Calcium; Calcium Channel Blocker; Blocker, Calcium Channel; Channel Blocker, Calcium;

CISMeF synonym : blockaders, exogenous calcium; inhibitors, exogenous calcium;

MeSH hyponym : Calcium Antagonists, Exogenous; Antagonists, Exogenous Calcium; Exogenous Calcium Inhibitors; Exogenous Calcium Antagonists; Exogenous Calcium Blockaders; Calcium Blockaders, Exogenous; Calcium Inhibitors, Exogenous; Exogenous Calcium Inhibitor; Calcium Inhibitor, Exogenous; Inhibitor, Exogenous Calcium; Exogenous Calcium Blockader; Blockader, Exogenous Calcium; Calcium Blockader, Exogenous;

MeSH annotation : vasodilators; D25-26 qualif; DF: CA CHANNEL BLOCK;

Wikipedia link : https://en.wikipedia.org/wiki/Calcium channel blocker;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D002121;

UMLS CUI

C0006684;

ATC code(s)
- isradipine [ATC Code]
ATC code(s)
- Angiotensin II receptor blockers (ARBs) and calcium channel blockers [ATC Code]
- Beta blocking agents and calcium channel blockers [ATC Code]
- ace inhibitors and calcium channel blockers [ATC Code]
- calcium channel blockers [ATC Code]
- calcium channel blockers and diuretics [ATC Code]
- calcium channel blockers and diuretics [ATC Code]
- dihydropyridine derivatives [ATC Code]
- nicardipine [ATC Code]
- non-selective calcium channel blockers [ATC Code]
- other non-selective calcium channel blockers [ATC Code]
- other selective calcium channel blockers with mainly vascular effects [ATC Code]
- selective calcium channel blockers with direct cardiac effects [ATC Code]
- selective calcium channel blockers with mainly vascular effects [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Poisoning caused by calcium-channel blockers (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Calcium Channel Blocker [NCIt concept]
- Calcium-channel blockers [Bloc CIM-11]
- Product containing calcium channel blocker (product) [SNOMED CT concept]
- Substance with calcium channel blocker mechanism of action (substance) [SNOMED CT concept]
- calcium channel blockers [ATC Code]
- calcium channel blocking agent, nos [SNOMED Notion]
False automatic mappings
- Calcium-channel blockers [ICD-10 Sub-category (who)]
- Calcium-channel blockers [ICD-10 Sub-category (who)]
- Inflammatory Collateral Cyst [NCIt concept]
- Poisoning by, adverse effect of and underdosing of calcium-channel blockers [ICD-10 Sub-category]
Indexing information
- 1-(3-chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione [MeSH Supplementary Concept]
- 2,2-dicyclohexyl-N-(2-(3-(trifluoromethyl)benzyl)octahydrocyclopenta(c)pyrrol-4-yl)acetamide [MeSH Supplementary Concept]
- 2,6-difluoro-N-(1-(2-fluoro-6-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide [MeSH Supplementary Concept]
- 2,6-difluoro-N-(1-(4-hydroxy-2-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide [MeSH Supplementary Concept]
- 3,5-dichloro-N-(1-(2,2-dimethyltetrahydropyran-4-ylmethyl)-4-fluoropiperidin-4-ylmethyl)benzamide [MeSH Supplementary Concept]
- A-1048400 [MeSH Supplementary Concept]
- AWD 160-275 [MeSH Supplementary Concept]
- MK-056 [MeSH Supplementary Concept]
- N-cyclopropyl-N-(1-((5-fluoro-2-(methylsulfonyl)phenyl)carbonyl)piperidin-4-yl)-3-(trifluoromethyl)benzenesulfonamide [MeSH Supplementary Concept]
- N-methyl-N'-(thiophen-3-methylene)benzo(d)(1,3)dioxole-5-carbohydrazide [MeSH Supplementary Concept]
- NMP-181 [MeSH Supplementary Concept]
- OF 5015 [MeSH Supplementary Concept]
- PD 173212 [MeSH Supplementary Concept]
- R 33956 [MeSH Supplementary Concept]
- azelnidipine [MeSH Supplementary Concept]
- ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate [MeSH Supplementary Concept]
- falicor [MeSH Supplementary Concept]
- nimesulide [MeSH Supplementary Concept]
- ryosidine [MeSH Supplementary Concept]
- tetramethylpyrazine [MeSH Supplementary Concept]
- vinpocetine [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Substance with dihydropyridine derivative structure and calcium channel blocker mechanism of action (substance) [SNOMED CT concept]
MeSH Descriptor(s) used for indexing
- calcium channel agonists [MeSH Descriptor]
- calcium channels [MeSH Descriptor]
- ryanodine receptor calcium release channel [MeSH Descriptor]
Record concept(s)
- Calcium Antagonists, Exogenous [MeSH concept]
- calcium channel blockers [MeSH concept]
See also
- anti-arrhythmia agents [MeSH Descriptor]
- antihypertensive agents [MeSH Descriptor]
- calcium channels [MeSH Descriptor]
- vasodilator agents [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone [MeSH Supplementary Concept]
- 1,4-dihydropyridine [MeSH Supplementary Concept]
- 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole [MeSH Supplementary Concept]
- 2-(4-(dimethylamino)styryl)-1-methylpyridinium [MeSH Supplementary Concept]
- 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate [MeSH Supplementary Concept]
- ACT-709478 [MeSH Supplementary Concept]
- AE0047 [MeSH Supplementary Concept]
- AH 1058 [MeSH Supplementary Concept]
- Amlodipine Besylate, Olmesartan Medoxomil Drug Combination [MeSH Descriptor]
- CD 349 [MeSH Supplementary Concept]
- Carvedilol [MeSH Descriptor]
- Conus magus toxin [MeSH Supplementary Concept]
- FTX, spider toxin [MeSH Supplementary Concept]
- IH 764-3 [MeSH Supplementary Concept]
- KT 362 [MeSH Supplementary Concept]
- Lamotrigine [MeSH Descriptor]
- N-(2-guanidinoethyl)-5-isoquinolinesulfonamide [MeSH Supplementary Concept]
- NNC 55-0396 [MeSH Supplementary Concept]
- PN 202-791 [MeSH Supplementary Concept]
- Pregabalin [MeSH Descriptor]
- R 56865 [MeSH Supplementary Concept]
- Risedronic Acid [MeSH Descriptor]
- SAN 202791 [MeSH Supplementary Concept]
- SOR-C13 [MeSH Supplementary Concept]
- Z160 [MeSH Supplementary Concept]
- Z944 [MeSH Supplementary Concept]
- Zonisamide [MeSH Descriptor]
- amlodipine [MeSH Descriptor]
- amlodipine, atorvastatin drug combination [MeSH Supplementary Concept]
- amrinone [MeSH Descriptor]
- anandamide [MeSH Supplementary Concept]
- anipamil [MeSH Supplementary Concept]
- azimilide [MeSH Supplementary Concept]
- bencyclane [MeSH Descriptor]
- benidipine [MeSH Supplementary Concept]
- bepridil [MeSH Descriptor]
- berbamine [MeSH Supplementary Concept]
- calciseptine [MeSH Supplementary Concept]
- canadine [MeSH Supplementary Concept]
- carboxyamido-triazole [MeSH Supplementary Concept]
- caroverine [MeSH Supplementary Concept]
- cilnidipine [MeSH Supplementary Concept]
- cinnarizine [MeSH Descriptor]
- clentiazem [MeSH Supplementary Concept]
- clevidipine [MeSH Supplementary Concept]
- conotoxins [MeSH Descriptor]
- darodipine [MeSH Supplementary Concept]
- dauricine [MeSH Supplementary Concept]
- devapamil [MeSH Supplementary Concept]
- diltiazem [MeSH Descriptor]
- dotarizine [MeSH Supplementary Concept]
- efonidipine [MeSH Supplementary Concept]
- emopamil [MeSH Supplementary Concept]
- enpiperate [MeSH Supplementary Concept]
- eperisone [MeSH Supplementary Concept]
- etripamil [MeSH Supplementary Concept]
- falipamil [MeSH Supplementary Concept]
- fantofarone [MeSH Supplementary Concept]
- fasudil [MeSH Supplementary Concept]
- felodipine [MeSH Descriptor]
- fenamic acid [MeSH Supplementary Concept]
- fendiline [MeSH Descriptor]
- flunarizine [MeSH Descriptor]
- fosfedil [MeSH Supplementary Concept]
- gallopamil [MeSH Descriptor]
- isradipine [MeSH Descriptor]
- lacidipine [MeSH Supplementary Concept]
- lercanidipine [MeSH Supplementary Concept]
- lidoflazine [MeSH Descriptor]
- lomerizine [MeSH Supplementary Concept]
- magnesium sulfate [MeSH Descriptor]
- manidipine [MeSH Supplementary Concept]
- manoalide [MeSH Supplementary Concept]
- mepirodipine [MeSH Supplementary Concept]
- mibefradil [MeSH Descriptor]
- monatepil [MeSH Supplementary Concept]
- naftopidil [MeSH Supplementary Concept]
- nicardipine [MeSH Descriptor]
- nifedipine [MeSH Descriptor]
- niguldipine [MeSH Supplementary Concept]
- niludipin [MeSH Supplementary Concept]
- nilvadipine [MeSH Supplementary Concept]
- nimodipine [MeSH Descriptor]
- nisoldipine [MeSH Descriptor]
- nitrendipine [MeSH Descriptor]
- norverapamil [MeSH Supplementary Concept]
- ochratoxin A [MeSH Supplementary Concept]
- octylonium [MeSH Supplementary Concept]
- omega-agatoxin IVA [MeSH Descriptor]
- omega-conotoxin GVIA [MeSH Descriptor]
- omega-conotoxin-MVIIC [MeSH Supplementary Concept]
- omega-conotoxins [MeSH Descriptor]
- osthol [MeSH Supplementary Concept]
- oxodipine [MeSH Supplementary Concept]
- perhexiline [MeSH Descriptor]
- pinaverium [MeSH Supplementary Concept]
- piperidine [MeSH Supplementary Concept]
- pranidipine [MeSH Supplementary Concept]
- prenylamine [MeSH Descriptor]
- ryodipine [MeSH Supplementary Concept]
- sesamodil [MeSH Supplementary Concept]
- stepholidine [MeSH Supplementary Concept]
- temiverine [MeSH Supplementary Concept]
- terodiline [MeSH Supplementary Concept]
- tetrahydropalmatine [MeSH Supplementary Concept]
- tetrandrine [MeSH Supplementary Concept]
- tiapamil hydrochloride [MeSH Descriptor]
- tolfenamic acid [MeSH Supplementary Concept]
- tranilast [MeSH Supplementary Concept]
- tylerdipine hydrochloride [MeSH Supplementary Concept]
- verapamil [MeSH Descriptor]
- ziconotide [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Calcium Channel Blocker [NCIt concept]
- Calcium channel blockers [LOINC hierarchical part]
- Calcium-channel blockers [ICD-10 Sub-category (who)]
- Calcium-channel blockers [Bloc CIM-11]
- Product containing calcium channel blocker (product) [SNOMED CT concept]
- Substance with calcium channel blocker mechanism of action (substance) [SNOMED CT concept]
- calcium channel blockers [ATC Code]
- calcium channel blocking agent, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients